NUS NuSkin Enterprises, Inc.
XNYS
4.03
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
NUS
$4.03
—
What changed
Recent filings, trades and movesKey stats
$4.03
- 52-Week Range
- $3.87 – $11.67
- YTD
- -58.41%
- IV Rank (30D)
- 100.0
- Straddle Price
- $1.07
- P/C Vol Ratio
- 0.07
- Market Cap
- $0.2B
- Open
- $4.01
- Day Range
- $3.95 – $4.10
- Volume
- 429,751
- Prev Close
- $4.01
Fair Value
+50.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.88% |
| Beta vs SPY | 0.96 |
| Cost of Equity (CAPM) | 9.69% (VRP-adj) |
| WACC | 7.48% |
| Volatility Risk Premium | +127.7pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | -39.9% |
| Book / Price | 278.5% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 69.2% |
| FCF Margin (TTM) | 0.8% |
| Debt / Equity | 0.36 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +0.7% (reverse-DCF on current price) |
| SMA 50 | $4.70 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $4.62 |
| Bollinger Width / SMA20 | 30.7% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $0B |
Peers used for multiples: ATR, COTY, IFF
(filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$12.21
Deviation
+50.0%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $2.01 | 25% | |
| DDM (Gordon) | $1.37 | 20% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | $31.93 | 7% | median 12.9× · 3 peers |
| Peer P/B | $17.42 | 10% | median 1.6× · 3 peers |
| Peer P/S | $63.39 | 10% | median 2.2× · 3 peers |
| Market Anchor (SMA50) | $4.70 | 29% | stability 60% (BB-width) |
| Options Expected (B-L 30d) | $3.68 | 0% | 5 strikes · skew +0.04 |
As of 2026-11-13 · updated
Related
About
- Industry (SIC)
- WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES (5122) · industry map
- Exchange
- XNYS
- Market Cap
- $0.2B
- Employees
- 8,600
- List Date
- 1996-11-22
- CIK
- 0001021561
- Last Earnings
- Nov 5 after close · −9.5% vs ±14.3% expected
- Next Earnings
- ~Feb 11, 2027 (estimated)
- Headquarters
- Provo, UT
- Homepage
- https://www.nuskin.com
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 4.55% | -8.00% | 1.49% | -8.66% | -0.15% | 9.49% | -0.21% |
| Feb | -11.96% | -9.15% | -10.03% | -33.79% | 23.36% | -19.47% | -10.17% |
| Mar | 0.36% | 5.93% | -3.42% | 9.41% | -5.22% | -9.90% | -0.47% |
| Apr | 0.13% | -12.66% | -2.38% | -12.76% | -12.33% | -0.82% | -6.80% |
| May | 13.53% | 4.95% | -16.76% | 12.85% | 40.10% | -19.47% | 5.87% |
| Jun | -7.02% | -7.44% | -1.25% | -22.10% | -4.08% | -6.22% | -8.02% |
| Jul | -5.24% | -2.71% | -12.37% | 7.88% | -5.42% | -1.89% | -3.29% |
| Aug | -5.96% | -8.12% | -19.67% | -18.45% | 48.41% | -9.11% | -2.15% |
| Sep | -20.76% | -18.03% | -11.59% | -14.80% | 0.58% | -0.88% | -10.91% |
| Oct | -3.21% | 11.80% | -8.53% | -12.94% | -10.74% | 2.20% | -3.57% |
| Nov | 7.58% | 6.48% | -8.59% | 15.14% | -7.57% | -15.69%* | -0.44% |
| Dec | 17.69% | 3.23% | 10.59% | -9.70% | -1.03% | -- | 4.16% |
| Total | -15.51% | -32.36% | -59.28% | -65.57% | 58.56% | -54.68% | -28.14% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $4.56
SMA 50: $4.68
SMA 200: $6.06
Current: $4.03
EMA 12: $4.30
EMA 26: $4.51
MACD: -0.2083 | Signal: -0.0842
BEARISH
ADX (14): 20.93
WEAK TREND
+DI: 13.89
−DI: 27.55
Momentum Oscillators
RSI (14): 36.94
NEUTRAL
Stoch %K: 8.07
Stoch %D: 7.50
Williams %R: -87.50
Volume & Volatility
BB Upper: $5.28
BB Lower: $3.85
NEUTRAL
OBV: -8,688,730
Vol SMA 20: 530,083
Vol ROC: 22.26%
ATR: $0.25
True Range: $0.15
HV 20: 67.6%
HV 30: 59.0%
HV 60: 48.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-15T00:00:00 – 2026-11-13T00:00:00
AI Analysis
Written before NUS’s Nov 5 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report - Nu Skin Enterprises (NUS)
Executive Summary
Overall Assessment: BEARISH with confidence level 6/10
Key Drivers:
- Strong downtrend in place, with prices below all major moving averages
- Bearish MACD signals and negative RSI readings support the bearish case
- High volatility and beta levels indicate a higher risk environment
Primary Risks:
- Technical breakdown potential from current levels
- High implied volatility may indicate increased uncertainty and market turbulence
Investment Thesis: NUS is experiencing a strong downtrend, driven by poor technical signals and negative news sentiment. The stock's high volatility and beta levels suggest a higher risk environment, making it challenging to predict short-term price movements.
Recent News Sentiment Impact: Neutral, with no significant impact on the stock's recent price action.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Bearish
- Medium-term (1-3 months): Bearish
- Long-term (3-12 months): Neutral
Support/Resistance Levels:
- SMA 20: $6.39
- EMA 12: $6.08
- Upper Bollinger Band: $7.53
Momentum Signals:
- RSI (14): Oversold at 29.87, indicating potential for a bounce
- MACD: Bearish signals with a negative histogram
- Bollinger Bands: Neutral signal, as price is neutral in relation to the bands
Volume Analysis:
- Volume SMA 20: 684558.00
- On-Balance Volume (OBV): -21518806.74 (bearish)
- Volume Rate of Change: -5.49% (bearish)
News & Sentiment Analysis
Recent Headlines Summary:
- Nu Skin Enterprises has been facing customer acquisition challenges, which may impact the company's growth prospects.
- The stock has experienced a significant decline in recent weeks, with no clear catalyst for the move.
Sentiment Assessment: Neutral, as there is no strong bullish or bearish sentiment driving the market.
Catalyst Identification:
- Earnings announcement (date TBA)
- Regulatory updates (industry news and guidance)
Market Narrative: The news sentiment has been neutral, with no significant impact on the stock's recent price action. The technical signals are bearish, indicating a potential breakdown from current levels.
Risk & Volatility Assessment
Risk Assessment: High risk, driven by the stock's high volatility and beta levels.
Beta Interpretation:
- Beta: 1.32 (vs SPY)
- High risk, as the stock moves more than the market.
Volatility Regime:
- Current vs historical volatility: Highly volatile
Options Market Signals:
- IV Rank: 100.0% (High - shows if volatility is historically high/low)
- Current IV: 239.3%
- Expected Move: $1.05 (20 DTE), 7-DTE: $1.05
- Volume Flow: 71 calls vs 26 puts
- Open Interest: 666 calls vs 159 puts
- Put/Call Volume Ratio: 0.37 (Bullish sentiment)
- Market Expectation: Options market pricing a $1.05 move by expiration
Market Context & Positioning
Sector Performance:
- Nu Skin Enterprises is part of the Consumer Goods sector, which has been performing relatively well.
Institutional Activity:
- Volume patterns suggest institutional interest in the stock.
Correlation Analysis:
- Correlation with SPY: 0.29 (positive but low)
Relative Valuation:
- Position within trading range: Below average
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $6.39
- EMA 12: $6.08
Breakout/Breakdown Levels:
- Lower Bollinger Band: $5.26 (support)
Time-Sensitive Catalysts:
- Earnings announcement (date TBA)
- Regulatory updates (industry news and guidance)
Risk Management:
- Stop-loss levels should be set near the SMA 20 ($6.39) to manage risk.
By analyzing the stock's technical indicators, news sentiment, and risk metrics, it appears that Nu Skin Enterprises is experiencing a strong downtrend, driven by poor technical signals and negative news sentiment. The high volatility and beta levels suggest a higher risk environment, making it challenging to predict short-term price movements.
Generated
News
All NUS news →
Rhyz manufacturing growth cushioned a steep core business decline this quarter.
Earnings History
20 of 24 under expected move
Avg Expected Move
11.35%
Avg Actual Move
6.77%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-11 | After-Close | 5.52% | 8.97% | 1.63x | Exceeded |
| 2021-05-05 | After-Close | 10.39% | 8.99% | 0.87x | Within |
| 2021-08-04 | After-Close | 11.17% | 4.54% | 0.41x | Within |
| 2021-10-04 | After-Close | 6.27% | 1.08% | 0.17x | Within |
| 2022-02-16 | After-Close | 3.50% | 1.43% | 0.41x | Within |
| 2022-05-04 | After-Close | 11.63% | 3.00% | 0.26x | Within |
| 2022-07-08 | After-Close | 2.06% | 1.06% | 0.51x | Within |
| 2022-11-02 | After-Close | 10.81% | 13.40% | 1.24x | Exceeded |
| 2023-02-15 | After-Close | 8.26% | 4.21% | 0.51x | Within |
| 2023-05-03 | After-Close | 8.01% | 3.32% | 0.41x | Within |
| 2023-08-01 | After-Close | 9.92% | 7.63% | 0.77x | Within |
| 2023-11-01 | After-Close | 12.35% | 9.45% | 0.77x | Within |
| 2024-01-08 | After-Close | 7.16% | 2.63% | 0.37x | Within |
| 2024-05-08 | After-Close | 9.90% | 2.90% | 0.29x | Within |
| 2024-08-08 | Pre-Market | 13.82% | 0.86% | 0.06x | Within |
| 2024-11-07 | Pre-Market | 16.59% | 0.46% | 0.03x | Within |
| 2025-02-13 | After-Close | 21.42% | 17.76% | 0.83x | Within |
| 2025-05-08 | After-Close | 24.35% | 11.04% | 0.45x | Within |
| 2025-08-07 | After-Close | 12.20% | 8.90% | 0.73x | Within |
| 2025-11-06 | After-Close | 12.23% | 15.79% | 1.29x | Exceeded |
| 2026-02-12 | After-Close | 15.67% | 18.12% | 1.16x | Exceeded |
| 2026-05-07 | After-Close | 13.53% | 1.99% | 0.15x | Within |
| 2026-08-10 | After-Close | 11.17% | 5.44% | 0.49x | Within |
| 2026-11-05 | After-Close | 14.35% | 9.49% | 0.66x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
NUS Options Activity & IV Rank
NUS IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 89.4%
7-DTE IV: —
Expected Move: $1.07
7-DTE Move: $2.20
Days to Exp: 35 (2026-12-18)
Options Flow · All expiries
Call Volume: 454
Put Volume: 33
P/C Volume: 0.073
BULLISH
Call OI: 6,007
Put OI: 479
P/C OI: 0.08
Total OI: 6,486
ATM Options Pricing
ATM Call: $0.10
ATM Put: $0.97
Call %: 2.5%
Put %: 24.2%
Chain Summary
Chain Volume: 487
Chain OI: 6,486
Last Updated: 11/13/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 67th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
67%
vs own history
GEX tilt
+0.90
OI-weighted, today
Vanna tilt
+0.87
δ-sensitivity to IV
Charm tilt
-0.91
δ-decay vs time
Vanna tilt +0.87: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.91: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 3 ATM contracts, 2k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Put vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol pointsThe same measure on the upside: how the OTM call is priced against the at-the-money strike.
- Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
- Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together
Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put
—
—
pts
EXTREME
as of Nov 13 · No data
30 DTE / 10d put
—
—
pts
EXTREME
as of Nov 13 · ATM 120.1% / Put —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)
IV Rank (30 DTE)100.0HighNov 13
Straddle Price (30 DTE)$1.07Nov 13
Beta Analysis
Risk Metrics
Beta: 0.7797
Alpha: -88.01%
Correlation: 0.2338
R-Squared: 5.5%
Stock Volatility: 45.5%
Market Volatility: 13.6%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own NUS
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $8.5M | #1149 of 3138 | -5.5% | 13F | |
| Citadel Hedge fund Ken Griffin | $3.5M | #2393 of 6285 | +187.9% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
NUS Institutional Ownership (13F)
Filings for 2026-06-30 · 55 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 49,440,500 (as of 2026-09-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
2 filers$123.55K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $122.50K | 99.15% | 2026-06-30 |
| 2 | Walleye Capital LLC | $1.06K | 0.85% | 2026-06-30 |
2 filers$399.17K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $201.70K | 50.53% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $197.47K | 49.47% | 2026-06-30 |
NUS Insider Trading (Form 4)
Latest: 2026-09-10Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Edwina D Woodbury | Director | Award (A) | +22 | $4.85 | $107 | EDGAR |
| 2026-06-11 | Edwina D Woodbury | Director | Award (A) | +19 | $5.43 | $103 | EDGAR |
| 2026-06-03 | Pisano R. Thomas | Director | Award (A) | +26,643 | — | EDGAR | |
| 2026-06-03 | Emma S. Battle | Director | Award (A) | +26,643 | — | EDGAR | |
| 2026-06-03 | Mark A Zorko | Director | Award (A) | +26,643 | — | EDGAR | |
| 2026-06-03 | Laura Nathanson | Director | Award (A) | +26,643 | — | EDGAR | |
| 2026-06-03 | James M Winett | Director | Mixed Grant +26,643 · Sell −7,203 |
+19,440 | $5.62 | -$40.5K | EDGAR |
| 2026-06-03 | Edwina D Woodbury | Director | Mixed Grant +26,643 · Sell −7,203 |
+19,440 | $5.70 | -$41.1K | EDGAR |
| 2026-06-03 | Daniel W Campbell | Director | Award (A) | +26,643 | — | EDGAR | |
| 2026-05-12 | Laura Nathanson | Director | Sell (S) | −2,676 | $6.73 | -$18.0K | EDGAR |
| 2026-03-12 | Edwina D Woodbury | Director | Award (A) | +14 | $7.31 | $102 | EDGAR |
| 2026-03-09 | Justin S Keisel | EVP, President of Global Sales | Award (A) | +47,059 | — | EDGAR | |
| 2026-03-09 | Steven Keith Hatchett | Chief Product Officer | Award (A) | +77,941 | — | EDGAR | |
| 2026-03-09 | Ryan S Napierski | President and CEO | Award (A) | +282,353 | — | EDGAR | |
| 2026-03-09 | James D Thomas | Chief Financial Officer | Award (A) | +114,706 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
NUS Insider Holdings
12 insiders · @ $4.03
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ryan S Napierski | President and CEO | 1,001,905 | $4.04M | -$13.76M | 58 | 2026-03-09 |
| 2 | Chayce David Clark | EVP, COO and CLO | 390,746 | $1.57M | -$239.4K | 28 | 2026-03-09 |
| 3 | James D Thomas | Chief Financial Officer | 267,102 | $1.08M | -$816.3K | 25 | 2026-03-09 |
| 4 | Steven Keith Hatchett | Chief Product Officer | 260,818 | $1.05M | -$997.0K | 22 | 2026-03-09 |
| 5 | Justin S Keisel | EVP, President of Global Sales | 160,170 | $645.5K | $0 | 8 | 2026-03-09 |
| 6 | Daniel W Campbell | Director | 129,244 | $520.9K | -$2.94M | 37 | 2026-06-03 |
| 7 | Pisano R. Thomas | Director | 116,827 | $470.8K | -$2.03M | 23 | 2026-06-03 |
| 8 | Edwina D Woodbury | Director | 62,474 | $251.8K | -$705.2K | 53 | 2026-09-10 |
| 9 | Mark A Zorko | Director | 60,586 | $244.2K | $0 | 3 | 2026-06-03 |
| 10 | Emma S. Battle | Director | 57,648 | $232.3K | -$125.8K | 10 | 2026-06-03 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
NUS Board & Officers
As of SEC filings through Sep 10, 2026Directors 9
- Daniel W Campbell · on file since May 2006
- Steven Lund · since Sep 7, 2006
- Pisano R. Thomas · since Jun 25, 2008
- Edwina D Woodbury · since Jun 23, 2015
- Laura Nathanson · since Jun 6, 2019
- Emma S. Battle · since Jun 2, 2021
- Ryan S Napierski · listed since Mar 2022
- Mark A Zorko · since Sep 10, 2024
- James M Winett · since May 29, 2025
Officers 4
- Ryan S Napierski · President and CEO · listed since Sep 2021
- Justin S Keisel · EVP, President of Global Sales · since Mar 14, 2024
- Chelsea K Lantz · Chief Financial Officer · since Mar 18, 2026
- Chayce David Clark · EVP and General Counsel · since Aug 1, 2021
Changes in the last 10 years (29)
| May 6, 2026 | The company announced the departure of Steven Keith Hatchett as Chief Product Officer in an SEC filing |
| Mar 18, 2026 | Chelsea K Lantz became Chief Financial Officer |
| Mar 17, 2026 | The company announced the departure of James D Thomas as Chief Financial Officer in an SEC filing |
| May 29, 2025 | James M Winett became a director |
| Mar 5, 2025 | The company announced the departure of Zheqing Shen from the board in an SEC filing |
| Sep 10, 2024 | Mark A Zorko became a director |
| Mar 15, 2024 | The company announced the departure of Andrew D Lipman from the board in an SEC filing |
| Mar 14, 2024 | Justin S Keisel became EVP, President of Global Sales |
| Feb 9, 2024 | The company announced the departure of Joseph Y Chang as Chief Scientific Officer in an SEC filing |
| Oct 27, 2023 | The company announced the departure of Connie Mang Yee Tang as Chief Global Growth Officer in an SEC filing |
| Jul 28, 2023 | James D Thomas listed as Chief Financial Officer (previously Chief Accounting Officer) in SEC filings |
| Mar 24, 2023 | The company announced the departure of Mark H Lawrence as Chief Financial Officer in an SEC filing |
| Mar 1, 2022 | Ryan S Napierski first listed as a director in an SEC filing |
| Mar 1, 2022 | Connie Mang Yee Tang listed as Chief Global Growth Officer (previously EVP Chief Global Growth &) in SEC filings |
| Feb 15, 2022 | Steven Keith Hatchett listed as Chief Product Officer (previously SVP, Global Products) in SEC filings |
| Feb 15, 2022 | Ryan S Napierski no longer listed as a director in SEC filings |
| Sep 1, 2021 | Steven Keith Hatchett became SVP, Global Products |
| Sep 1, 2021 | Ryan S Napierski listed as President and CEO (previously President) in SEC filings |
| Sep 1, 2021 | Ryan S Napierski first listed as a director in an SEC filing |
| Sep 1, 2021 | Jeffrey Clark Bettinger became SVP, People and Places Officer |
| Aug 1, 2021 | Chayce David Clark became EVP and General Counsel |
| Jun 2, 2021 | Emma S. Battle became a director |
| Apr 21, 2021 | Connie Mang Yee Tang became EVP Chief Global Growth & |
| Aug 1, 2019 | James D Thomas became Chief Accounting Officer |
| Jun 6, 2019 | Laura Nathanson became a director |
| Sep 5, 2017 | Ritch N Wood first listed as a director in an SEC filing |
| Jul 26, 2017 | Ryan S Napierski listed as President (previously Pres Global Sales & Operations) in SEC filings |
| Jun 29, 2017 | Ritch N Wood listed as Chief Executive Officer (previously Chief Financial Officer) in SEC filings |
| Mar 27, 2017 | Mark H Lawrence became Chief Financial Officer |
Not reported recently (8)
- Jeffrey Clark Bettinger · Last reported as SVP, People and Places Officer in an SEC filing dated Oct 5, 2021
- D Matthew Dorny · Last reported as General Counsel in an SEC filing dated Jul 6, 2021
- Ritch N Wood · Last reported as Chief Executive Officer in an SEC filing dated Jun 21, 2021
- Nevin N Andersen · Last reported as a director in an SEC filing dated May 22, 2019
- Neil H Offen · Last reported as a director in an SEC filing dated May 22, 2019
- Ping An ZQ China Growth Opportunity Ltd · Last reported as a director in an SEC filing dated Mar 9, 2018
- Zhequing Shen · Last reported as a director in an SEC filing dated May 15, 2017
- M Truman Hunt · Last reported as a director in an SEC filing dated Mar 27, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
NUS Proposed Insider Sales (Form 144)
Latest: 2026-06-02
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | Winett James M | Director | 7,203 | $40.5K | 2026-06-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-01 | WOODBURY EDWINA D | Director | 7,203 | $41.1K | 2026-06-01 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-11 | Nathanson Laura | Director | 2,676 | $19.2K | 2026-05-11 | William Blair and Company LLC | — | EDGAR |
| 2025-09-04 | Nathanson Laura | Director | 6,489 | $77.9K | 2025-09-04 | William Blair | — | EDGAR |
| 2025-09-03 | Clark Chayce David | Officer | 20,000 | $239.4K | 2025-09-03 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-08-29 | CAMPBELL GIFT TRUST | Director | 23,391 | $283.1K | 2025-08-29 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-08-29 | DANIEL WAYNE CAMPBELL & PEGGY CAMPBELL | Director | 9,046 | $109.6K | 2025-08-29 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-06-02 | WOODBURY EDWINA D | Director | 4,532 | $38.3K | 2025-06-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-06-02 | Battle Emma S. | Director | 4,532 | $38.3K | 2025-06-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-02-21 | Battle Emma S. | Director | 1,693 | $13.1K | 2025-02-21 | Fidelity Brokerage Services LLC | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-06
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
53 ETFs hold NUS
25 shown · $47.49M total exposure · 0.02% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.03% | $10.5M | $32.8B | 2026-11-12 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $6.6M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $5.4M | $76.8B | 2026-11-12 |
| 4 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.04% | $3.9M | — | 2026-08-31 |
| 5 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $2.5M | — | 2026-09-30 |
| 6 | VDC Vanguard Consumer Staples ETF | Vanguard | 0.03% | $2.5M | — | 2026-09-30 |
| 7 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.01% | $2.2M | — | 2026-11-12 |
| 8 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.01% | $2.0M | $13.9B | 2026-11-12 |
| 9 | DES WisdomTree U.S. SmallCap Dividend Fund | Nport | 0.06% | $1.4M | — | 2026-06-30 |
| 10 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.00% | $1.3M | — | 2026-11-12 |
| 11 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $1.3M | — | 2026-09-30 |
| 12 | BSVO EA Bridgeway Omni Small-Cap Value ETF | Nport | 0.05% | $1.2M | — | 2026-06-30 |
| 13 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.00% | $1.1M | — | 2026-08-31 |
| 14 | AFMC First Trust Active Factor Mid Cap ETF | First Trust | 0.25% | $674,290 | $267.9M | 2026-11-12 |
| 15 | ISMD Inspire Small/Mid Cap ETF | Nport | 0.18% | $614,756 | — | 2026-08-31 |
| 16 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.05% | $598,376 | $1.2B | 2026-11-12 |
| 17 | VFVA Vanguard U.S. Value Factor ETF | Vanguard | 0.06% | $598,244 | — | 2026-11-12 |
| 18 | JPSE JPMorgan Diversified Return U.S. Small Cap Equity ETF | JPMorgan | 0.09% | $499,591 | $572.0M | 2026-11-13 |
| 19 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $490,624 | — | 2026-11-12 |
| 20 | SMLF iShares U.S. Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.01% | $474,423 | $4.3B | 2026-11-12 |
| 21 | AFSM First Trust Active Factor Small Cap ETF | First Trust | 0.25% | $370,917 | $148.8M | 2026-11-12 |
| 22 | SEIS SEI Select Small Cap ETF | Nport | 0.06% | $356,331 | — | 2026-06-30 |
| 23 | DGRS WisdomTree U.S. SmallCap Quality Dividend Growth Fund | Nport | 0.09% | $351,801 | — | 2026-06-30 |
| 24 | GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | Goldman | 0.03% | $347,635 | $1.1B | 2026-11-12 |
| 25 | MYLD Cambria Micro and SmallCap Shareholder Yield ETF | Nport | 0.99% | $336,566 | — | 2026-07-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-4.84
TTM Revenue
$1.32B
TTM Net Income
$-234.21M
TTM Op. Cash Flow
$15.21M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | $311.01M | $-742.00K | $-0.02 | $-8.12M |
| Q2 '26 | 2026-06-30 | $320.11M | $-249.80M | $-5.14 | $10.62M |
| Q1 '26 | 2026-03-31 | $320.61M | $1.84M | $0.04 | $-3.92M |
| Q4 '25 | 2025-12-31 | $370.32M | $14.49M | $0.28 | $16.62M |
| Q3 '25 | 2025-09-30 | $364.21M | $17.08M | $0.34 | $27.48M |
| Q2 '25 | 2025-06-30 | $386.14M | $21.12M | $0.43 | $35.80M |
| Q1 '25 | 2025-03-31 | $364.49M | $107.52M | $2.14 | $389.00K |
| Q4 '24 | 2024-12-31 | $445.55M | $-36.10M | $-0.72 | $25.79M |
| Q3 '24 | 2024-09-30 | $430.14M | $8.30M | $0.17 | $31.43M |
| Q2 '24 | 2024-06-30 | $439.08M | $-118.26M | $-2.38 | $51.21M |
| Q1 '24 | 2024-03-31 | $417.31M | $-533.00K | $-0.01 | $3.32M |
| Q4 '23 | 2023-12-31 | $488.64M | $7.28M | $0.14 | $54.17M |
Q3 2026 • period ending 2026-09-30 • filed 2026-11-06
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
0.37
P/S
0.15
EV/EBITDA
1.70
EV/Sales
0.15
ROE
-39.9%
ROA
-19.3%
Div Yield
5.95%
FCF Yield
25.29%
Debt/Equity
0.36
Current Ratio
—
Market Cap
$200.89M
as of 2026-11-13
NUS vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| ABBV ABBVIE INC. | $520.5B | 50.8 | +10.7% | +28.7% | 26 |
| CL Colgate-Palmolive Company | $77.8B | 39.1 | +5.9% | +28.3% | 38 |
| EL The Estee Lauder Companies Inc. Class A | $40.0B | 111.8 | +5.8% | +4.7% | 16 |
| ULTA Ulta Beauty, Inc. Common Stock | $27.8B | 24.1 | +11.2% | +6.6% | 78 |
| IFF International Flavors & Fragrances Inc. | $20.1B | 106.8 | −1.9% | +19.3% | 16 |
| ATR AptarGroup, Inc. | $9.0B | 34.7 | +9.0% | +16.8% | 21 |
| ELF e.l.f. Beauty, Inc. | $6.7B | 81.4 | +39.9% | +51.6% | 2 |
| COTY COTY INC | $3.6B | — | −0.2% | +29.9% | 14 |
| NUS NuSkin Enterprises, Inc. | $195M | — | −15.3% | −58.4% | 100 |
| Peer median | $24.0B | 50.8 | +7.5% | +23.8% | 18 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
4.46M
SI % of Float
9.44%
Days to Cover
11.33
Short Vol Ratio
29.8%
Free Float
47.22M
Float %
97.0%
Short interest 2026-10-30 • Short volume 2026-11-13 • Float 2026-08-14